Head-to-head · WeighScore
Actin vs Aurelius Health Group
The verdict
Aurelius Health Group takes it — 62.3/100 to 58.8/100.
Aurelius Health Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine,…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Actin | Aurelius Health Group |
|---|---|---|
| WeighScore | 58.8/100 | 62.3/100 |
| Grade | C | C |
| Scorecard rank | #355 | #275 |
| Semaglutide | $169/mo (compounded) | Not disclosed |
| Tirzepatide | Not disclosed | $199/mo (microdose tier, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #355 · C
Strengths
- Semaglutide paired with B12 for added energy support
- Transparent pricing — exact cost shown upfront with no hidden fees
- Competitive pricing from $116/mo on the 6-month plan ($169/mo month-to-month)
Where it loses points
- Semaglutide only — no tirzepatide or liraglutide
- No visible LegitScript or PCAB accreditation
- States served not disclosed
- Broad platform spanning hormones, sexual wellness, and hair health
Graded #275 · C
Strengths
- Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
- LegitScript Certified
- Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
- Unusually candid about the limited evidence base for microdosing
Where it loses points
- Microdose-only model — sub-therapeutic doses have thinner trial evidence and likely smaller weight loss than full-dose tirzepatide
- No semaglutide or standard full-dose option
- No named compounding pharmacy partner
- No state list and no named medical director or pharmacist-in-charge
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.